Infant Formula ยท Research guide

DHA, ARA, HMOs, GOS and FOS

Separate fatty acids, oligosaccharides and study-specific evidence when reading formula claims.

Sources reviewed

Different ingredients, different functions

DHA and ARA are fatty acids. HMOs are human milk oligosaccharides; GOS and FOS are galacto- and fructo-oligosaccharides. These names are not interchangeable, and GOS is not a protein. The EU composition regulation addresses fatty-acid composition and specified oligosaccharide additions separately.

An ingredient listing identifies an addition. It does not establish the quantity, the current physical label, or a clinical effect for that product.

Read the actual study

A 2017 randomized trial studied a formula containing 2'-FL and LNnT in 175 infants. Growth was similar between groups; reported morbidity differences were secondary findings needing confirmation. The research had manufacturer affiliations.

That result belongs to those ingredients, concentrations, formulation and study population. It is not evidence that a higher HMO count produces better outcomes, or that all formulas with HMOs reproduce the result.

How our filters work

We use ingredient-source information where it is supported and keep claims qualified. Unreviewed automatic ingredient splits do not become verified HMO filters or nutrient totals. Missing quantitative panels remain missing. For clinical needs, marketing terms and ingredient counts do not replace a clinician's recommendation.

General formula research supports informed questions. Specialized feeding needs and diagnosed allergies require clinical guidance for the infant and exact product.

Sources

  1. EU Regulation 2016/127: fatty acids and oligosaccharides, European Commission (2016)
  2. Puccio et al.: two human milk oligosaccharides randomized trial, Journal of Pediatric Gastroenterology and Nutrition (2017)

Return to formula research and comparison